Malaysia and Thailand Launch Regulatory Reliance Pilot

In February 2026, Malaysia’s Medical Device Authority (MDA) and the Thai Food and Drug Administration (Thai FDA) formally launched a pilot Regulatory Reliance Programme for medical devices.

This initiative marks a significant step toward deeper regulatory collaboration within ASEAN and reflects a broader global shift toward reliance-based assessment models.

What Is the Regulatory Reliance Pilot?

The pilot programme enables Malaysia and Thailand to leverage each other’s regulatory assessments when reviewing medical device applications.

Rather than duplicating full technical evaluations, participating authorities may rely on prior scientific assessments conducted by the partner regulator, particularly for higher-risk medical devices (Class B, C and D).

The objective is clear:

• Reduce duplication in regulatory review

• Improve efficiency in approval timelines

• Strengthen trust between competent authorities

• Facilitate faster access to safe and effective medical technologies

  
  

Why This Matters for Industry

For manufacturers targeting both Malaysia and Thailand, this development introduces important strategic considerations.

Reliance pathways can:

• Shorten time-to-market across both jurisdictions

• Reduce documentation redundancy

• Enhance regulatory predictability

• Lower overall market entry costs

However, reliance does not eliminate regulatory responsibility. Companies must still ensure:

• Robust technical documentation

• Consistent submission strategies across markets

• Clear alignment of product classification and intended use

  
  

A Broader ASEAN Signal

This pilot reflects a larger movement toward regulatory convergence across Southeast Asia.

ASEAN regulators are increasingly exploring reliance, work-sharing, and harmonisation models to:

• Strengthen regional competitiveness

• Improve patient access

• Build regulatory capacity

• Align with international best practices

  
  

If successful, this Malaysia–Thailand collaboration could serve as a model for future ASEAN-level reliance mechanisms.

Strategic Takeaway

For global manufacturers and regional distributors, this is more than a bilateral agreement; it is a signal of where regulatory systems are heading.

Reliance frameworks require proactive regulatory planning. Companies that align documentation, quality systems, and submission strategies across markets will be best positioned to benefit.

At ARQon, we continue to monitor regulatory reliance developments across Asia to help our partners anticipate structural shifts in approval pathways and optimise regional market access strategies.